Stay tuned and follow the latest developments and news in Molecular Oncology.
Genekor participated in the San Antonio Breast Cancer Symposium (#SABCS), held on December 9–12, 2025 in Texas, one of the leading international scientific congresses dedicated to breast cancer research and clinical management.
During the congress, four poster presentations were presented, showcasing contemporary clinical research data.
📌 Poster presentations
Poster 1: Integrated NGS-Based Tissue and Plasma Profiling to Advance Precision Oncology in Breast Cancer.
Poster 2: Association of Oncotype DX Recurrence Score with Germline Mutations in Cancer Susceptibility Genes, Including BRCA1/2, in HR+/HER2− Early Breast Cancer.
Poster 3: Retrospective Observational Study of Premenopausal ER+/HER2− Patients in Greece with Axillary Tumor Burden but Low Oncotype DX® Recurrence Score Who Did Not Receive Chemotherapy.
Poster 4: High Prevalence of NF1 Pathogenic Variants in Cancer Patients without Classic Features of Neurofibromatosis Type 1.
We are proud to have once again participated in research studies that were presented during the congress.